In Depth Research on Global Non Small Cell Lung Cancer Market & Pipeline Insight

“Global Non Small Cell Lung Cancer Market & Pipeline Insight” Report Highlights:

* NSCLC Therapy Market Overview
* Mechanism of NSCLC Therapeutics
* NSCLC Therapy Market Dynamics: Drivers, Challenges & Future Prospects)
* NSCLC Drug Pipeline by Phase, Company & Country
* NSCLC Clinical Pipeline: 268 Drugs
* Majority of NSCLC Drugs in Phase-II Trials: 99
* Marketed NSCLC Drugs: 30

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-Global-Non-Small-Cell-Lung-Cancer-Market-&-Pipeline-Insight.php

Table of Contents

1. Introduction to Non Small Cell Lung Cancer

2. Mechanism of Non Small Cell Lung Cancer Therapeutics

3. Non Small Cell Lung Cancer Therapy Market Overview
3.1 Market Scenario
3.2 Non Small Cell Lung Cancer Pipeline Overview

4. Non Small Cell Lung Cancer Therapy Market Dynamics
4.1 Market Drivers
4.2 Challenges

5. Non Small Cell Lung Cancer Therapy Market Future Prospects

6. Non Small Cell Lung Cancer Drug Pipeline by Phase, Company & Country
6.1 Unknown
6.2 Research
6.3 Preclinical
6.4 Clinical
6.5 Phase-I
6.6 Phase-I/II
6.7 Phase-II
6.8 Phase-II/III
6.9 Phase-III
6.10 Preregistration
6.11 Registered

7. Marketed Non Small Cell Lung Cancer Drugs

8. Suspended & Discontinued Non Small Cell Lung Cancer Drug Pipeline
8.1 No Development Reported
8.2 Discontinued
8.3 Suspended

9. Competitive Landscape
9.1 AstraZeneca
9.2 Biodesix
9.3 Chugai Pharmaceutical
9.4 Eli Lily
9.5 GlaxoSmithKline
9.6 Merck
9.7 Novartis AG
9.8 Pfizer
9.9 Roche
9.10 Transgene

Figure 1-1: Classification of Lung Cancer
Figure 1-2: Treatments Available for NSCLC
Figure 1-3: Categorization of NSCLC on The Basis of Stages
Figure 2-1: Steps Involved in NSCLC Metastasis
Figure 2-2: Mechanism of Tyrosine Kinase Inhibitors
Figure 2-3: Mechanism of Angiogenesis Inhibitors
Figure 2-4: Mode of Action of NSCLC Vaccines
Figure 3-1: Non Small Cell Lung Cancer Pipeline by Phase (%), 2015
Figure 3-2: Non Small Cell Lung Cancer Pipeline by Phase (Number), 2015
Figure 3-3: No Development Reported in Non Small Cell Lung Cancer Pipeline by Phase (%), 2015
Figure 3-4: No Development Reported in Non Small Cell Lung Cancer Pipeline by Phase (Number), 2015
Figure 3-5: Discontinued Non Small Cell Lung Cancer Pipeline by Phase (%), 2015
Figure 3-6: Discontinued Non Small Cell Lung Cancer Pipeline by Phase (%), 2015
Figure 3-7: Suspended Non Small Cell Lung Cancer Pipeline by Phase (%), 2015
Figure 3-8: Suspended Non Small Cell Lung Cancer Pipeline by Phase (Number), 2015

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.